Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-20 Sale | 2025-02-24 4:21 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 3,305 | $4.26 | $14,079 | 215,718 (Direct) | View |
| 2025-02-20 Sale | 2025-02-24 4:20 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 11,702 | $4.24 | $49,616 | 731,816 (Direct) | View |
| 2025-02-20 Sale | 2025-02-24 4:19 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO | 3,894 | $4.25 | $16,550 | 312,147 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 4:22 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,413 | $4.45 | $24,088 | 81,023 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 4:21 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO | 6,950 | $4.45 | $30,928 | 102,291 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 4:20 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President & CEO | 16,644 | $4.45 | $74,066 | 308,518 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 4:19 pm | Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer | 4,358 | $4.45 | $19,393 | 81,643 (Direct) | View |
| 2025-01-14 Sale | 2025-01-15 4:18 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO | 3,087 | $5.09 | $15,713 | 109,241 (Direct) | View |
| 2025-01-14 Sale | 2025-01-15 4:17 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 1,191 | $5.13 | $6,110 | 86,436 (Direct) | View |
| 2024-12-23 Sale | 2024-12-26 4:29 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin COO&CBO | 6,500 | $5.65 | $36,725 | 112,328 (Direct) | View |
| 2024-10-02 Sale | 2024-10-03 4:43 pm | Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer | 5,999 | $5.82 | $34,914 | 86,001 (Direct) | View |
| 2024-04-02 Sale | 2024-04-03 4:13 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 1,357 | $9.88 | $13,407 | 117,004 (Direct) | View |
| 2024-04-02 Sale | 2024-04-03 4:10 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 12,115 | $9.86 | $119,454 | 322,839 (Direct) | View |
| 2024-02-21 Sale | 2024-02-22 4:36 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 3,966 | $7.45 | $29,547 | 118,361 (Direct) | View |
| 2024-02-21 Sale | 2024-02-22 4:34 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 13,033 | $7.46 | $97,226 | 334,954 (Direct) | View |
| 2024-02-21 Sale | 2024-02-22 4:32 pm | Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer | 3,764 | $7.46 | $28,079 | 175,669 (Direct) | View |
| 2024-02-20 Sale | 2024-02-22 4:30 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 3,967 | $7.5019 | $29,760 | 87,627 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-21 Option Award | 2025-02-24 4:21 pm | N/A 2035-02-21 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 138,000 | $0 | 215,718 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-24 4:20 pm | N/A 2035-02-21 | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 435,000 | $0 | 731,816 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-24 4:19 pm | N/A 2035-02-21 | Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO | 213,750 | $0 | 312,147 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-24 4:18 pm | N/A 2035-02-21 | Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer | 124,500 | $0 | 206,143 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-24 4:16 pm | N/A 2035-02-21 | Voyager Therapeutics Inc. | VYGR | Ferguson Toby Chief Medical Officer | 189,000 | $0 | 294,000 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-24 4:15 pm | N/A 2035-02-21 | Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer | 154,500 | $0 | 234,500 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-02 4:09 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2024-07-08 Option Award | 2024-07-09 4:11 pm | N/A 2034-07-08 | Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:22 pm | N/A 2034-06-05 | Voyager Therapeutics Inc. | VYGR | Vitale Nancy Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:21 pm | N/A 2034-06-05 | Voyager Therapeutics Inc. | VYGR | SCANGOS GEORGE A Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:20 pm | N/A 2034-06-05 | Voyager Therapeutics Inc. | VYGR | PIERCE GLENN Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:20 pm | N/A 2034-06-05 | Voyager Therapeutics Inc. | VYGR | Onyia Jude Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:19 pm | N/A 2034-06-05 | Voyager Therapeutics Inc. | VYGR | MACKEY CATHERINE J Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:17 pm | N/A 2034-06-05 | Voyager Therapeutics Inc. | VYGR | Hyman Steven Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:16 pm | N/A 2034-06-05 | Voyager Therapeutics Inc. | VYGR | Higgins Michael J Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:15 pm | N/A 2034-06-05 | Voyager Therapeutics Inc. | VYGR | GERAGHTY JAMES A Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:15 pm | N/A 2034-06-05 | Voyager Therapeutics Inc. | VYGR | Colon Grace Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 4:17 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Ferguson Toby Chief Medical Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-26 5:27 pm | N/A 2034-03-25 | Voyager Therapeutics Inc. | VYGR | Ferguson Toby Chief Medical Officer | 210,000 | $0 | 210,000 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-16 5:06 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer | 93,000 | $0 | 154,000 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-16 5:04 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 115,500 | $0 | 168,594 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-16 5:03 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 150,000 | $0 | 222,327 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-16 4:59 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 390,000 | $0 | 607,987 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-16 4:58 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer | 90,000 | $0 | 239,433 (Direct) | View |